Mediastinal infusion with tracheal necrosis: An unusual complication of Port-a-cath devices

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Port-a-cath (PAC) is a catheter totally implanted under the skin. It is commonly used in oncology for permanent venous access. It provides a more simple way to infuse chemotherapies, antibiotics or parenteral nutrition, while offering improved comfort to patients. The usual complications of these devices (infections and catheter obstructions) are well documented. More exceptional events are catheter fractures with systemic migration, and endopleural perfusions due to a wrong positioning of the catheter. Since 1998, 10 cases of mediastinal infusion of cytotoxics have been reported. Surgical management was necessary in only two cases. We are reporting the case of a 57-yearold female suffering from a multimetastatic sigmoid adenocarcinoma. A mediastinal infusion of Folfiri and bevacizumab with a tracheal necrosis complicated the PAC use and required a latissimus dorsi myoplasty to fill up the tracheo-bronchial defect. © 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.

Cite

CITATION STYLE

APA

Renaud, S., Santelmo, N., Falcoz, P. E., & Massard, G. (2011). Mediastinal infusion with tracheal necrosis: An unusual complication of Port-a-cath devices. Interactive Cardiovascular and Thoracic Surgery, 12(6), 1007–1009. https://doi.org/10.1510/icvts.2010.264903

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free